BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+11.69%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.02B
AUM Growth
+$1.02B
(+3.9%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
51.66%
Holding
52
New
9
Increased
8
Reduced
25
Closed
1
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$36.7M |
| 2 |
Merus
MRUS
|
$34M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$23.8M |
| 4 |
Galmed Pharmaceuticals
GLMD
|
$21M |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$17.9M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$94.4M |
| 2 |
ARQL
Arqule Inc
ARQL
|
$49.7M |
| 3 |
ESSA Pharma
EPIX
|
$36.4M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$14M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$6.55M |
Sector Composition
| 1 | Healthcare | 83.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
1
DELISTED
ChemoCentryx, Inc.
CCXI
| $92.6M | 9.04% | 7,034,346 -166,970 | -2% | -$2.2M |
|
|
2
Merus
MRUS
$4.98B
| $89.1M | 8.7% | 3,914,913 +1,495,470 | +62% | +$34M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $78.4M | 7.65% | 4,672,195 -390,573 | -8% | -$6.55M |
|
4
Cytokinetics
CYTK
$4.23B
| $46.1M | 4.5% | 5,550,890 -170,998 | -3% | -$1.42M |
|
|
ARQL
5
DELISTED
Arqule Inc
ARQL
| $41.2M | 4.02% | 7,447,912 -8,989,000 | -55% | -$49.7M |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $41.1M | 4.01% | 646,811 -8,800 | -1% | -$559K |
|
7
Kura Oncology
KURA
$686M
| $37.4M | 3.65% | 2,057,346 +703,500 | +52% | +$12.8M |
|
|
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $36.7M | 3.58% | +745,000 | New | +$36.7M |
|
|
CTIC
9
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $34.5M | 3.37% | 6,929,690 | – | – |
|
10
Xencor
XNCR
$580M
| $32.2M | 3.14% | 869,645 -32,355 | -4% | -$1.2M |
|
11
Xoma
XOMA
$392M
| $31.4M | 3.06% | 1,502,800 | – | – |
|
|
CNCE
12
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $30.6M | 2.98% | 1,817,138 -114,985 | -6% | -$1.94M |
|
|
INFI
13
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $29.1M | 2.84% | 15,232,268 +5,465,760 | +56% | +$10.4M |
|
|
PVLA
14
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $27.1M | 2.65% | 5,346,838 +1,754,289 | +49% | +$8.89M |
|
15
AnaptysBio
ANAB
$569M
| $23.8M | 2.32% | 335,265 -50,800 | -13% | -$3.61M |
|
|
16
Ionis Pharmaceuticals
IONS
$6.79B
| $23.8M | 2.32% | +570,000 | New | +$23.8M |
|
|
BLRX
17
BioLineRX
BLRX
$16.2M
| $23.5M | 2.3% | 25,995,575 | – | – |
|
|
FWP
18
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $23.1M | 2.26% | 8,503,425 +3,748,308 | +79% | +$10.2M |
|
|
19
Galmed Pharmaceuticals
GLMD
$6.96M
| $21M | 2.05% | +1,761,567 | New | +$21M |
|
20
Corvus Pharmaceuticals
CRVS
$428M
| $20.8M | 2.03% | 1,890,507 -63,747 | -3% | -$700K |
|
|
IMDZ
21
DELISTED
Immune Design Corp.
IMDZ
| $18.9M | 1.85% | 4,158,353 +52,153 | +1% | +$237K |
|
|
FPRX
22
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $17.9M | 1.74% | +1,129,761 | New | +$17.9M |
|
23
Verastem
VSTM
$569M
| $15.4M | 1.51% | 2,242,353 -494,647 | -18% | -$3.4M |
|
24
Spero Therapeutics
SPRO
$116M
| $15.4M | 1.5% | 1,048,958 | – | – |
|
25
MEI Pharma
MEIP
$160M
| $12.1M | 1.18% | +3,080,308 | New | +$12.1M |
|